Search hospitals > Alberta > CALGARY
University of Calgary
Claim this profileCALGARY, Alberta T2N 4Z6
Global Leader in Crohn's Disease
Global Leader in Hepatitis
Conducts research for Diabetes
Conducts research for Hepatitis A
Conducts research for Heart Failure
420 reported clinical trials
50 medical researchers
Summary
University of Calgary is a medical facility located in CALGARY, Alberta. This center is recognized for care of Crohn's Disease, Hepatitis, Diabetes, Hepatitis A, Heart Failure and other specialties. University of Calgary is involved with conducting 420 clinical trials across 450 conditions. There are 50 research doctors associated with this hospital, such as John Anderson, MD, Prism Schneider, MD, Robert S Sheldon, MD, PhD, and Eric Smith, MD.Top PIs
John Anderson, MDClinical Research Center of Alabama4 years of reported clinical research
Studies Angioedema
Studies Hereditary Angioedema
9 reported clinical trials
11 drugs studied
Prism Schneider, MDFoothills Medical Centre5 years of reported clinical research
Studies Broken Bones
Studies Wounds and Injuries
9 reported clinical trials
13 drugs studied
Robert S Sheldon, MD, PhDUniversity of Calgary2 years of reported clinical research
Studies Atrial Fibrillation
Studies Fainting
9 reported clinical trials
12 drugs studied
Eric Smith, MDUniversity of Calgary4 years of reported clinical research
Studies Alzheimer's Disease
Studies Cognitive Impairment
7 reported clinical trials
8 drugs studied
Clinical Trials running at University of Calgary
Depression
Deep Vein Thrombosis
Rapid Heartbeat
Postural Orthostatic Tachycardia Syndrome
Osteoarthritis
Blood Clot
Type 1 Diabetes
Fainting
Vasovagal Syncope
Diabetes
Escitalopram + Brexpiprazole
for Depression
This study is evaluating whether a biomarker algorithm can predict treatment outcome for patients with a major depressive episode.
Recruiting3 awards Phase 48 criteria
ATTACHâ„¢ Virtual Parenting Program
for Children's Mental Health
COVID-19 has placed unprecedented strains on parents impacted by toxic stressors (depression, addiction, family violence, and poverty) and reluctant to see mental health-service providers in home/clinic due to fears of infection. Due to the pandemic, PI Letourneau ceased/delayed recruitment in ATTACHâ„¢, a CIHR-funded randomized controlled trials (RCT) of in-person (home or clinic) program designed to improve children's mental, emotional and behavioral (MEB) health and development via parent-child relationship intervention. Recognizing the heightened need for already vulnerable families to obtain safe parenting support to manage depressive symptoms/other stressors. The team's primary knowledge user (D. McNeil, Scientific Director, Maternal Newborn Child and Youth Strategic Clinical Network, Alberta Health Services) advocated for online delivery of the ATTACHâ„¢ parent training program. In response, an interdisciplinary team from nursing and software engineering rapidly pivoted to an online delivery format. Critical barriers to using existing commercial technologies emerged, making it essential to develop and implement tailored, user-informed virtual care delivery platforms and tools safe, secure, user-friendly for families already stressed. Innovative user interface design and integrated knowledge transfer approaches will be used to: (a) adapt ATTACHâ„¢ for virtual delivery; (b) develop virtual platforms (web-based applications) and tools (mobile apps) for flexible delivery of mental health supports for parents and training for professional facilitators; (c) integrate virtual mental health services into the primary care system promoting program uptake; and (d) design/test streamlined and intuitive virtual systems for nimble spread/scaleup. The project catalyzes and enriches the PIs' research program by crossing disciplines (nursing & engineering) in cutting edge research that is responsive to trends in both mental health intervention and web-interface design. The aim is to adapt, develop, design and pilot test virtual (web-based) intervention program to improve children's mental, emotional and behavioral (MEB) health and development. This will be done by building on successful CIHR funded in-person (home or clinic) programs and pivoting to user-engaged program development, adaptation and pilot testing for virtual delivery in the face of COVID19.
Recruiting1 award N/A4 criteria
Cannabidiol
for Bipolar Depression
Bipolar disorder (BD) is a lifelong condition characterized by recurrent episodes of depression and (hypo) mania. Periods of chronic and recurring depressive episodes are more common and can be severely disabling. Effective treatments exist; however, a significant portion of bipolar depressed patients do not respond to or have difficulty tolerating many of these interventions and thus look beyond established treatments to achieve symptom relief. Cannabidiol (CBD), a chemical from the Cannabis sativa plant has shown to have some beneficial effects on mood symptoms in a few small studies which assessed its effects in other mental and physical health conditions, but no large studies have been conducted to assess the safety and efficacy in bipolar depression. Additionally, several clinical studies have shown CBD to be safe and tolerable. The primary objective of this study is to assess the effectiveness, safety and tolerability of Cannabidiol in patients with bipolar depression (BD I or BD II) who have not responded to adequate trials with at least one first-line treatment for bipolar depression in comparison to those who will be treated with placebo. Placebo is an inactive substance that looks identical to the study medication but contains no therapeutic ingredient. This study is a randomized (like the flip of a coin), double-blind (you and the study team will not know which treatment arm you receive) study in which participants will receive either CBD or placebo added to their current treatment. Participants will have 5 clinical appointments and a phone appointment over a period of 10 weeks.
Recruiting1 award Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Calgary?
University of Calgary is a medical facility located in CALGARY, Alberta. This center is recognized for care of Crohn's Disease, Hepatitis, Diabetes, Hepatitis A, Heart Failure and other specialties. University of Calgary is involved with conducting 420 clinical trials across 450 conditions. There are 50 research doctors associated with this hospital, such as John Anderson, MD, Prism Schneider, MD, Robert S Sheldon, MD, PhD, and Eric Smith, MD.
Where is University of Calgary located?
**University of Calgary Hospital**
- **Address:** 3330 Hospital Dr NW, Calgary, AB T2N 4N1.
- For the most efficient route, consider using real-time driving directions from Waze or MapQuest.
Who should I call to ask about financial aid or insurance network?
**University of Calgary Financial Assistance Contact Information:**
- **Financial Assistance and Loans Office:**
- **Address:** 2500 University Drive NW, Calgary, AB, Canada T2N 1N4
- **Email:** riskmgmt@ucalgary.ca
- **Phone:** 403.210.9502
- **Hours:** 8:30 a.m. - noon & 1 p.m. - 4:30 p.m., Monday - Friday (Excluding lunch hours and statutory holidays)
- **Risk Management and Insurance Department:**
- **Address:** Math Sciences, Room 255, 2500 University Drive N.W., Calgary, Alberta T2N 1N4
- **Email:** riskmgmt@ucalgary.ca
- **Phone:** 403.210.9502
- **Hours:** 8:30 a.m. - noon & 1 p.m. - 4:30 p.m., Monday - Friday (Excluding lunch hours and statutory holidays)
- **Emergency Financial Assistance:**
- Contact an Enrolment Services advisor for emergency financial assistance and application access.
What insurance does University of Calgary accept?
The University of Calgary accepts the following insurance plans:
1. **Alberta Health Care Insurance Plan (AHCIP)** - Covers basic services such as doctor visits, laboratory tests, and hospital costs. Does not include prescription drugs, dental, vision care, or ambulance transport.
2. **Students Union (SU) Health and Dental Plan** - Available to full-time undergraduate students, covering prescription drugs, dental services, vision care, ambulance transport, and more.
3. **Graduate Students Association (GSA) Health & Dental Plan** - For full-time graduate students, offering similar coverage as the SU Health and Dental Plan.
4. **Manulife University of Calgary Health and Dental Insurance** - Provides extended health care including prescriptions, dental care, vision, massage therapy, and more.
5. **Private medical insurance plans** - Required for international exchange and visiting students, as they are not eligible for AHCIP.
What awards or recognition has University of Calgary received?
The University of Calgary Hospital, located in Calgary, Alberta, is renowned for its exceptional research and care initiatives. It is particularly noted for the "One Child Every Child" research initiative, focused on the health and empowerment of children. The hospital's commitment to healthcare excellence is further underscored by the induction of eight of its researchers into the Canadian Academy of Health Sciences.